What is Tourmaline Bio Inc Annual Net Profit?

Tourmaline Bio Inc Annual Net Profit fell 73.8% in the last year to $73.21 M. Its sector's average net profit growth for the last fiscal year was -32.43%.

What is Tourmaline Bio Inc Price to Earning Ratio?

Tourmaline Bio Inc Price to Earning Ratio is -6.02, which is negative.

What is Tourmaline Bio Inc Stock Price?

Tourmaline Bio Inc Stock Price fell 40.06% and underperformed its sector by 49.13% in the past year.

What is Tourmaline Bio Inc Quarterly Net profit?

Tourmaline Bio Inc Quarterly Net profit fell 72.34% YoY to $22.24 M. Its sector's average net profit growth YoY for the quarter was -47.3%.

What is Tourmaline Bio Inc Mutual Fund Holding?

Tourmaline Bio Inc Mutual Fund Holding decreased by 0.8% in the last quarter to 23.72.

What is Tourmaline Bio Inc Institutional Holding?

Tourmaline Bio Inc Institutional Holding increased by 7% in the last quarter to 88.76.

How is the Tourmaline Bio Inc today?

The Tourmaline Bio Inc today is trading in the green, up by 1.60% at 17.15.

How has Tourmaline Bio Inc performed historically?

The Tourmaline Bio Inc is currently trading up 1.60% on an intraday basis in the past week the index fell -8.78%. The index has been down -16.95% in the past quarter and fell -40.06% in the past year. You can view this in the overview section.

Tourmaline Bio Inc XNAS: TRML

Tourmaline Bio Inc Live Share Price Today, Share Analysis and Chart

Name: Tourmaline Bio Inc: Is Infosys Ltd. worth buying?
Item: Tourmaline Bio Inc
Rating: 1.43275
Author: Trendlyne DVM scores

Download real time

17.15 0.27 (1.60%)

42.43% Fall from 52W High

751.2K XNAS Volume

High volume today

XNAS 21 Mar, 2025 5:30 PM (EDT)

Tourmaline Bio Inc Key Metrics

My Metrics

Default

Market Capitalization Below industry Median Unavailable in chosen country	440.5
PE TTM Negative PE TTM Unavailable in chosen country	-6
PEG TTM Below industry Median Unavailable in chosen country	0.1
Price to Book Below industry Median Unavailable in chosen country	1.4
Institutional holding current Qtr % High in industry Unavailable in chosen country	88.8
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-72.3
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-73.8
Rel Perf vs Sector quarter% Unavailable in chosen country	-25.6

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

9.5 / 100

Technically Neutral

47.8 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Tourmaline Bio Inc Stock Price Analysis

Day Price Range 1.6% 1 Day return Unavailable in chosen country	17.2 (LTP) 16.717.5 LowHigh
Week Price Range -8.8% 1 Week return Unavailable in chosen country	17.2 (LTP) 16.218.8 LowHigh
Month Price Range 40.5% 1 Month return Unavailable in chosen country	17.2 (LTP) 11.918.8 LowHigh
52 Week Price Range -40.1% 1 Year return Unavailable in chosen country	17.2 (LTP) 11.929.8 LowHigh

View full Share Price History

Tourmaline Bio Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Tourmaline Bio Inc Stock Analysis

Tourmaline Bio Inc stock analysis with key metrics, changes, and trends.

Tourmaline Bio Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$73.21 M	73.8%	negative	Annual Net Profit fell 73.8% in the last year to $73.21 M. Its sector's average net profit growth for the last fiscal year was -32.43%.
Price to Earning Ratio	-6.02	-	negative	Price to Earning Ratio is -6.02, which is negative.
Stock Price	$17.15	-40.06%	negative	Stock Price fell 40.06% and underperformed its sector by 49.13% in the past year.
Quarterly Net profit	$22.24 M	72.34%	negative	Quarterly Net profit fell 72.34% YoY to $22.24 M. Its sector's average net profit growth YoY for the quarter was -47.3%.
Mutual Fund Holding	23.72 %	-0.8%	negative	Mutual Fund Holding decreased by 0.8% in the last quarter to 23.72.
Institutional Holding	88.76 %	7%	positive	Institutional Holding increased by 7% in the last quarter to 88.76.

VIEW LESS

Loading data..

Tourmaline Bio Inc - Company Profile

What does Tourmaline Bio Inc do?

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Gross Remuneration

2024

Gross Remuneration

Year

Tourmaline Bio Inc Live Share Price Today, Share Analysis and Chart

42.43% Fall from 52W High

High volume today

Tourmaline Bio Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Rel Perf vs Sector quarter%

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Tourmaline Bio Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Tourmaline Bio Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Tourmaline Bio Inc Stock Analysis

Tourmaline Bio Inc stock analysis with key metrics, changes, and trends.

Annual Net Profit fell 73.8% in the last year to $73.21 M. Its sector's average net profit growth for the last fiscal year was -32.43%.

Price to Earning Ratio is -6.02, which is negative.

Stock Price fell 40.06% and underperformed its sector by 49.13% in the past year.

Quarterly Net profit fell 72.34% YoY to $22.24 M. Its sector's average net profit growth YoY for the quarter was -47.3%.

Mutual Fund Holding decreased by 0.8% in the last quarter to 23.72.

Institutional Holding increased by 7% in the last quarter to 88.76.

Tourmaline Bio Inc - Company Profile

What does Tourmaline Bio Inc do?

Tourmaline Bio Inc Management structure

Mr. W. Bradford Middlekauff, J.D.

Corporate Secretary, Chief Business Officer and General Counsel

Mr. Ryan F. Robinson

Principal Accounting Officer, Chief Financial Officer and Treasurer

Dr. Yung H. Chyung, M.D.

Executive Vice President and Chief Medical Officer

Dr. Sandeep C. Kulkarni, M.D.

Chief Executive Officer and Director

Tourmaline Bio Inc Board of directors

Mr. Mark D. Mcdade

Independent Director

Dr. Clay B. Siegall,PhD

Chairman of the Board

Dr. Sapna Srivastava, PhD

Independent Director

Dr. Caley Castelein, M.D.

Independent Director

Mr. Aaron Kantoff

Independent Director

Dr. Sandeep C. Kulkarni, M.D.

Chief Executive Officer and Director

Tourmaline Bio Inc FAQ

How is Tourmaline Bio Inc today?

Tourmaline Bio Inc today is trading in the green, and is up by 1.60% at 17.15.

How has Tourmaline Bio Inc performed historically?

Tourmaline Bio Inc is currently trading up 1.60% on an intraday basis. In the past week the stock fell -8.78%. stock has been down -16.95% in the past quarter and fell -40.06% in the past year. You can view this in the overview section.